Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
about
Taxanes: vesicants, irritants, or just irritating?Pain related to cancer treatments and diagnostic procedures: a no man's land?Use of allogeneic platelet gel in the management of chemotherapy extravasation injuries: a case report.Identification of Risk Factors for Intravenous Infiltration among Hospitalized Children: A Retrospective Study.Extravasation injuries in adults.Adverse mucocutaneous reactions related to chemotherapeutic agents: part II.Dermatologic manifestations of cytotoxic therapy.Management of extravasation injuries: a focused evaluation of noncytotoxic medications.Extravasation of antineoplastic agents: prevention and treatments.Management of the extravasation of anti-neoplastic agents.Acyclovir-induced bullous reaction in a patient with metastatic breast cancer.Injury due to extravasation of thiopental and propofol: Risks/effects of local cooling/warming in rats.Dermatological toxicity in women with breast cancer undergoing chemotherapy treatment.Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists.Pharmacological management of anticancer agent extravasation: A single institutional guideline.Extravasation of Noncytotoxic Drugs: A Review of the Literature.Cutaneous manifestations of phosphate solution extravasation.Extravasation reactions associated with the administration of pamidronate: 11 cases (2008-2013).Diagnostic accuracy of the Catheter Injection and Aspiration (CINAS) classification for assessing the function of totally implantable venous access devices.
P2860
Q26851427-7A7F70F2-1A4F-4ADA-A04E-6336F1B935F4Q27026749-745DAFA9-331D-49BE-81E0-1D2FECD318D0Q35094449-C8DC744B-CC35-4718-AA64-A06910FE7AA8Q36063070-18FC7B2E-FACD-4C7A-B934-9C3355351837Q36877135-EC743CA7-FCE2-4662-A458-EFB542485DB0Q37820276-9D147A28-1292-433A-9B3C-5C3FEB10DA23Q37930714-DD804AC2-08E5-4D3E-B756-F0E42C31F791Q38178196-88001DE2-766A-45BA-8B58-60D20B584942Q38268101-913C16DD-293A-4E56-9F1C-D6126DC3CDF6Q38364842-2A9692DA-527B-4A7E-9C9D-2F07934F93AFQ40890156-1BE51542-10E0-4E21-8DC3-9A53CAD0B45AQ41682641-62F6A209-FED4-4DDA-93DF-4F945F9B5B1EQ46147788-EC59226C-27E3-4FE9-AC4E-6AEBD497D017Q46171458-3CEA6505-DB3B-4C7D-8618-01E786012DBEQ47238461-4BBBBB97-D408-414A-AAD8-E2AF2618EA67Q47886612-3F14D895-0F3C-4ADE-86F7-897A35C8F97FQ48106334-208D3698-8224-4CA8-ACC9-4B7350560D74Q50240361-5DE714B3-B001-471A-B8BE-561953F00346Q51834629-DE45F545-5052-4CB8-B4D9-17335D765D45
P2860
Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
@ast
Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
@en
type
label
Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
@ast
Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
@en
prefLabel
Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
@ast
Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
@en
P2093
P356
P1476
Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
@en
P2093
Carmel Sauerland
Constance Engelking
Dominick Corbi
Rita Wickham
P304
P356
10.1188/06.ONF.1134-1141
P577
2006-11-27T00:00:00Z